Skip to main content

Bankrupt Aceto plans chemical disposal

4th March 2019

Submitted by:

Andrew Warmington

Aceto, a US-headquartered distributor active in the pharmaceuticals, chemicals and related sectors, has entered Chapter 11 bankruptcy and announced plans to sell the chemicals related part of its business. It has consequently entered into a ‘stalking horse’ agreement with New Mountain Capital, under which it will sell these interests for $338 million plus the assumption of certain liabilities and subject to certain adjustments, on a cash- and debt-free basis, unless a better bid comes forward before the end of its fiscal year on 30 June.

The company, which owed its creditors about $349 million, made a 10-Q filing with the Securities & Exchange Commission in New York on 20 February in order to facilitate a court-supervised auction of its business segments Section 363 of the US Bankruptcy Code, according to analysts. It is expected that shareholders will lose their investments.

The parts of the business covered by the agreement with New Mountain are the Pharmaceutical Ingredients and Performance
Chemical segments, plus the Nutritionals portion of the Human Health segment. The deal also covers the company’s non-US chemicals business subsidiaries, although they are not part of the bankruptcy filing.

Aceto likewise plans to sell its struggling generic drugs business, Rising Pharmaceuticals, in a similar process. It has also entered into $60 million debtor-in-possession financing from a syndicate led by Wells Fargo in order to secure enough working capital to continue normal business while the process of selling these operations goes ahead.

CEO William Kennally said that the board had for several months “been conducting a comprehensive evaluation of strategic alternatives to address the company’s debt burden in consultation with its financial and legal advisors, while continuing to work cooperatively with its lenders”. It concluded that this was the best option, as it  “provides stability and deep capital resources to the company and, importantly, ensures the continuity of customer, partner and supplier relationships critical to the company’s businesses operations and success”.

Aceto dates back to 1947 and has business operations in nine countries. It distributes over 1,100 chemical compounds that are used mainly as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. It has offices in both China and India active in sourcing these materials.

The generics business had been struggling for some time and, in April 2018, Aceto announced that “light of the persistent adverse conditions” in this market, it was negotiating with a waiver of its credit agreement with respect to its total net leverage and debt service coverage financial covenants for Q1 2019 with its bank lenders. It anticipated recording non-cash intangible asset impairment charges of $230-260 million on certain current and pipeline generic products “as a result of continued intense competitive and pricing pressures”.

In addition to making changes at the top, Aceto said at the time that it had “initiated a process to identify and evaluate a range of strategic alternatives”, potentially including sale of a key business segment(s), a merger or other business combination with another party, continuing as a standalone entity. It retained a financial advisor and legal counsel to assist in this process, but in the end no solution was found.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington